Bottrop, Germany

Kai Steenweg

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Evonik Industries Ag. Active years: 2014.


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kai Steenweg in Siloxane Chemistry

Introduction

Kai Steenweg is a notable inventor based in Bottrop, Germany. He has made significant contributions to the field of siloxane chemistry, particularly through his innovative patent related to nitrone-bearing siloxanes. His work has implications for the development of advanced materials used in various applications.

Latest Patents

Steenweg holds a patent titled "Siloxane nitrones and use thereof." This invention focuses on the production of nitrone-bearing siloxanes and their application as additives for radiation-curable coatings. The patent showcases his expertise in creating materials that enhance the performance of coatings in industrial applications. He has 1 patent to his name.

Career Highlights

Kai Steenweg is associated with Evonik Industries AG, a leading global company specializing in specialty chemicals. His role at Evonik allows him to work on cutting-edge projects that push the boundaries of material science. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Throughout his career, Steenweg has collaborated with talented professionals, including Frauke Henning and Bjoern Eicke. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Kai Steenweg's work in siloxane chemistry exemplifies the impact of innovative thinking in the field of materials science. His patent on nitrone-bearing siloxanes highlights his commitment to advancing technology and improving industrial applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…